» Articles » PMID: 23090487

Mechanisms of Mesenchymal Stromal Cell Immunomodulation

Overview
Publisher Wiley
Date 2012 Oct 24
PMID 23090487
Citations 262
Authors
Affiliations
Soon will be listed here.
Abstract

Multipotent mesenchymal stromal cells (MSCs) have generated considerable interest in the fields of regenerative medicine, cell therapy and immune modulation. Over the past 5 years, the initial observations that MSCs could enhance regeneration and modulate immune responses have been significantly advanced and we now have a clearer picture of the effects that MSCs have on the immune system particularly in the context of inflammatory-mediated disorders. A number of mechanisms of action have been reported in MSC immunomodulation, which encompass the secretion of soluble factors, induction of anergy, apoptosis, regulatory T cells and tolerogenic dendritic cells. It is clear that MSCs modulate both innate and adaptive responses and evidence is now emerging that the local microenvironment is key in the activation or licensing of MSCs to become immunosuppressive. More recently, studies have suggested that MSCs have the capacity to sense their environment and have a role in pathogen clearance in conjunction with the resolution of insult or injury. This review focuses on the mechanisms of MSC immunomodulation discussing the multistep process of MSC localisation at sites of inflammation, the cross talk between MSCs and the local microenvironment as well as the subsequent mechanisms of action used to resolve inflammation.

Citing Articles

MSCs-EVs harboring OA immune memory reprogram macrophage phenotype via modulation of the mt-ND3/NADH-CoQ axis for OA treatment.

Zhan J, Zou J, Pang Q, Chen Z, Liu J, Liu S J Nanobiotechnology. 2025; 23(1):140.

PMID: 40001168 PMC: 11863759. DOI: 10.1186/s12951-025-03216-1.


Bibliometric mapping of mesenchymal stem cell therapy for bone regeneration from 2013 to 2023.

Chen Q, Su Y, Yang Z, Lin Q, Ke Y, Xing D Front Med (Lausanne). 2025; 11():1484097.

PMID: 39835103 PMC: 11743382. DOI: 10.3389/fmed.2024.1484097.


Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis.

Wang T, Li M, Shang H, Zou L, Shang F Cent Eur J Immunol. 2024; 49(3):273-281.

PMID: 39720270 PMC: 11664808. DOI: 10.5114/ceji.2024.144866.


Intraosseous Delivery of Mesenchymal Stem Cells for the Treatment of Bone and Hematological Diseases.

Artamonov M, Sokov E Curr Issues Mol Biol. 2024; 46(11):12672-12693.

PMID: 39590346 PMC: 11592824. DOI: 10.3390/cimb46110752.


Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells.

Hazrati A, Mirarefin S, Malekpour K, Rahimi A, Khosrojerdi A, Rasouli A Front Immunol. 2024; 15:1469696.

PMID: 39582867 PMC: 11581898. DOI: 10.3389/fimmu.2024.1469696.